MedTrace Logo

Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma

NCT00912847 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1018

Last updated 2009-06-03

No results posted yet for this study

Summary

The purpose of this study is:

1. To establish and compare the diagnostic utilities for hepatocellular carcinoma (HCC) screening tests of (a) HS-AFP, (b) AFP + US,(c) AFP alone and (d) US alone (within HBV carriers between age 40 and 70 years);
2. To establish the cost-effectiveness of the screening tests;
3. To compare tumor sizes, resection rates, and survival rates up to 18 months between those who were screened by HS-AFP those of a historical control group that was not screened.

Conditions

  • Hepatitis B Virus

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-10-31
Primary Completion
2004-04-30
Completion
2004-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00912847 on ClinicalTrials.gov